Please activate JavaScript

To experience the full functionality of this website you need JavaScript. Instructions on how to enable JavaScript in your browser can be found here.

goetzpartners advised TÜV Süd

goetzpartners advised TUEV SUED in the acquisition of MSource Group

Sell-Side Advisory

Healthcare and Life Sciences

Transaction

goetzpartners advised

TÜV Süd on the

Acquisition

of MSOURCE from its founder, Dr. Adriaan Hart de Ruijter

Scroll down

TÜV SÜD AG, through its subsidiary TÜV SÜD Life Science GmbH, acquired all shares of clinical research organisation Msource Group, headquartered in Kraainem, Belgium, for an undisclosed consideration.

goetzpartners Munich acted as the exclusive financial advisor to TÜV SÜD. We were responsible for the definition of the high-level strategy to expand into a new business segment, the identification of potential targets in the CRO sector and advised in all steps of the Msource acquisition process.

More transactionsYou might also be interested in...

Fortlane Partners advised

Exyte on the

of TTP Group

goetzpartners advised

Evotec SE on its

of Central Glass Germany GmbH

goetzpartners advised

EvoTec SE on the

of Rigenerand Srl

230,000,00 €

goetzpartners advised

Otto Group on the

of Medgate Holding & Better Doc

goetzpartners advised

Pharmaron on its

of Aesica Pharmaceuticals from Recipharm

goetzpartners advised

doctari group on the

of Planerio GmbH

goetzpartners advised

Pharmaron on its

of Allergan Biologics from AbbVie

goetzpartners advised

EUSA Pharma on the

of the global commercialization rights to the oncology product ISQETTE

goetzpartners advised

Penta Investment on the

of Lloyds Pharma

goetzpartners advised

Penta Investment on the

of Gehe Pharma

goetzpartners advised

KKR and Triton on the

Acquisition

of Ambea

goetzpartners advised

Chequers Capital on the

Acquisition

of Silver Care Holding

goetzpartners advised

a financial investor on the

Acquisition

of the Four Seasons Health Care Group